Learn how to use this product
The LONZA human recombinant insulin is produced according to cGMP and labeled For Further Manufacturing"(FFM). GMP Products are intended for research or further manufacturing use only. The products confirm cGMP manufacturing compliance expectations for medical devices, including 21 CFR Part 820 and ISO 13485. Do not use this product for direct therapeutic use in humans.
ProCHO mand PowerCHO media do not contain significant amounds of insulin. This insulin may be vital in some cases for protein production in CHO cells.